Baxter International

More Than 100 Days After Hurricane Maria, Drug Shortages Situation Expected to Improve
More Than 100 Days After Hurricane Maria, Drug Shortages Situation Expected to Improve
RAPS.org
hurricanes
drug shortages
drug manufacturing
Puerto Rico
Baxter International
Flag link:
Illinois AG sues Baxter for polluting lake
Illinois AG sues Baxter for polluting lake
Drug Delivery Business News
Illinois
Baxter International
pollution
R&D
devices
Flag link:
Closing Claris deal, Baxter set to invest in three new plants
Closing Claris deal, Baxter set to invest in three new plants
BioPharma Dive
Baxter International
Claris
drug manufacturing
Flag link:
Baxter CEO Almeida on creating a bridge between invention and innovation
Baxter CEO Almeida on creating a bridge between invention and innovation
Medical Design and Outsourcing
Baxter International
Jose Almeida
innovation
Flag link:
Baxalta bets again on Kamada with lung transplant deal
Baxalta bets again on Kamada with lung transplant deal
Fierce Biotech
Baxalta
Kamada
lung transplants
Baxter International
Flag link:
Baxter launches a new biotech with the Mayo Clinic in tow
Baxter launches a new biotech with the Mayo Clinic in tow
Fierce Biotech
Baxter International
Mayo Clinic
Velocity Pharmaceuticals
Vitesse Biologics
Flag link:
Novo Nordisk rejects Baxter patent claim over Novoeight
Novo Nordisk rejects Baxter patent claim over Novoeight
Yahoo/Reuters
Novo Nordisk
Baxter International
NovoEight
Flag link:
Baxter looks to growth post-Baxalta spinout
Baxter looks to growth post-Baxalta spinout
Mass Device
Baxter International
Baxalta
devices
Flag link:
Merrimack Pharmaceuticals and Baxter BioScience Announce Completion of New Drug Application Submission to U.S. FDA for MM-398 as a Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer
Merrimack Pharmaceuticals and Baxter BioScience Announce Completion of New Drug Application Submission to U.S. FDA for MM-398 as a Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer
Yahoo
Merrimack Pharmaceuticals
Baxter International
MM-398
metastatic pancreatic cancer
Flag link:
Baxter's latest hemophilia drug comes through in Phase III
Baxter's latest hemophilia drug comes through in Phase III
Fierce Biotech
Baxter International
hemophilia
BAX 817
Flag link:
Baxter backs away from vaccines with Vero tech sale to Nanotherapeutics
Baxter backs away from vaccines with Vero tech sale to Nanotherapeutics
Fierce Vaccines
Baxter International
vaccines
M&A
Vero
Nanotherapeutics
Flag link:
Hot Drugmakers Build More Labs, Grab Space In Boston
Hot Drugmakers Build More Labs, Grab Space In Boston
Investors.com
Boston
Biogen Idec
Baxter International
Agios Pharmaceuticals
Pfizer
Flag link:
Pfizer closes $635M vaccines purchase from Baxter
Pfizer closes $635M vaccines purchase from Baxter
Yahoo/AP
Pfizer
vaccines
M&A
Baxter International
Flag link:
Under siege by Biogen's new long-acting Eloctate, Baxter's Advate stands its ground
Under siege by Biogen's new long-acting Eloctate, Baxter's Advate stands its ground
Fierce Pharma Marketing
Biogen Idec
Elocate
Baxter International
Advate
Flag link:
FDA clears Baxter hemophilia A treatment
FDA clears Baxter hemophilia A treatment
Seeking Alpha
Baxter International
FDA
hemophilia A
Obizur
Flag link:
Baxter prepping for HyQvia launch with spinoff's success on the line
Baxter prepping for HyQvia launch with spinoff's success on the line
Fierce Pharma
Baxter International
HyQvia
primary immunodeficiency
Flag link:
Medical products push Baxter profit above estimate
Medical products push Baxter profit above estimate
Yahoo/Reuters
Baxter International
earnings
devices
Flag link:
Merrimack Does Well to License Marginal Cancer Drug to Baxter
Merrimack Does Well to License Marginal Cancer Drug to Baxter
TheStreet.com
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Baxter International
Flag link:
Baxter and Halozyme sway the FDA after a painful rejection
Baxter and Halozyme sway the FDA after a painful rejection
Fierce Biotech
Baxter International
Halozyme
FDA
HyQvia
Flag link:
Report: In a big split, Baxter looks to relocate biopharma to Boston
Report: In a big split, Baxter looks to relocate biopharma to Boston
Fierce Biotech
Baxter International
Boston
Flag link:

Pages